Popular Articles

Protecting Against Obesity And Atherosclerosis By Blocking A Muscle Growth-Limiting Hormone
Knockout of myostatin, a growth factor that limits muscle growth, can decrease body fat and promote resistance against developing atherosclerosis, or "hardening" of the arteries, according to a new study conducted in mice. The results were presented at The Endocrine Society"s 91st Annual Meeting in Washington, D.C.

Divisions Over Future Medicare Spending Surface In House
"A week-old agreement among House Democrats to smooth out disparities in the way Medicare reimburses rural and urban health providers is in danger of crumbling, as disputes erupted Friday over what actually was agreed to," The Wall Street Journal reports. "Some lawmakers from states with high health-care costs are also pressing House Democratic leaders for changes to the deal to ensure that their doctors and hospitals don"t see too big of a bite. ò€¦ Lawmakers from populous areas are questioning whether the deal on geographic disparities should be altered to allow more time for Medicare changes to take effect, since there is no longer the urgency of putting those changes into effect before the public option is rolled out. Another issue is for how long a period of time after changes go into effect urban hospitals should be "held harmless," meaning they won"t see their Medicare reimbursements cut" (Vaughan, 8/2).
News of the day
WHO And EFA Call For Global Action On Chronic Respiratory Disease
The World Health Organisation (WHO) and European Federation of Allergy and Airways Diseases (EFA) today announced that they are bringing together over 150 international delegates to discuss the growing epidemic of Chronic Respiratory Diseases (CRD) that affects one billion people worldwide1, [2], [3] and is responsible for four million deaths annually1. The conference which will discuss the implementation of a five-year initiative to unite policy makers, providers and patient groups will be hosted by the Italian Ministry of Health in Rome on June 12 and 13.
Cardiovascular

Even Mildly Abnormal Blood Sugar Levels During Pregnancy Increases Risk Of Developing Type 2 Diabetes

Gestational diabetes happens in more than three per cent of pregnancies in Ontario. Usually the condition resolves itself after delivery, but many studies have shown that these women are at a very high risk for developing "regular" type 2 diabetes later in life. New research out of the Institute for Clinical Evaluative Sciences (ICES) has found that even women with mild abnormalities in their blood sugar during pregnancy, previously thought not to have any clinical significance, are 2.5 times more likely to develop type 2 diabetes compared to those who had completely normal glucose testing. * To test for gestational diabetes, women receive a glucose challenge test (GCT) in the late second trimester of pregnancy. If the result of this test is abnormal, they go on to have a diagnostic test, called the oral glucose tolerance test (OGTT). If this test does not show gestational diabetes, women are reassured their glucose levels are normal and that no further testing is needed. * However, recent studies have suggested that women who have even mild abnormalities on either the GCT or the OGTT do actually have subtle differences in their metabolism after pregnancy. * The study examined 15,000 pregnant women aged 20-49 in Ontario who had a mild abnormality on their GCT but did not ultimately get diagnosed with gestational diabetes. They were compared to about 60,000 pregnant women who did not have abnormalities on their GCT. The women were followed for 6.4 years after delivery, and those who had had an abnormal GCT were 2.5 times more likely to develop type 2 diabetes compared to those who had not had an abnormal GCT. "These results show that even a mild abnormality in glucose testing during pregnancy is associated with an increased risk of diabetes later in life. Although we already know that women who"ve had gestational diabetes need to be monitored, the study suggests that even women with mild glucose abnormalities might benefit from diabetes prevention and detection strategies," says Baiju Shah, ICES researcher. Author affiliations: ICES (Shah), Mount Sinai Hospital (Retnakaran), Sunnybrook Health Sciences Centre (Shah); Ontario. The study "Abnormal Screening Glucose Challenge Test in Pregnancy and Future Risk of Diabetes in Young Women" is in the May, 2009 issue of Diabetic Medicine. Deborah Creatura Institute for Clinical Evaluative Sciences


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):